Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Canaria Therapeutics, Inc. See All Filings	D/A	2021-06-02 12:00:04 UTC
Amount To Be Raised $23,100 Associated Brokers / Dealers N/A CIK Number 0001754404 Filed Document 0001754404-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-06-02 12:00:04 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business ALABAMA Revenue or Assets Decline to Disclose Type of Security Equity
Canaria Therapeutics, Inc. See All Filings	D/A	2020-06-10 16:07:33 UTC
Amount To Be Raised $23,100 Associated Brokers / Dealers N/A CIK Number 0001754404 Filed Document 0001754404-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-06-10 16:07:33 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business ALABAMA Revenue or Assets Decline to Disclose Type of Security Equity
Canaria Therapeutics, Inc. See All Filings	D/A	2020-03-04 15:44:37 UTC
Amount To Be Raised $23,100 Associated Brokers / Dealers N/A CIK Number 0001754404 Filed Document 0001754404-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-03-04 15:44:37 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business ALABAMA Revenue or Assets Decline to Disclose Type of Security Equity
Canaria Therapeutics, Inc. See All Filings	D	2019-07-01 17:46:31 UTC
Amount To Be Raised $5,000 Associated Brokers / Dealers N/A CIK Number 0001754404 Filed Document 0001754404-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-07-01 17:46:31 UTC Type of Offering D Industry Biotechnology Principal Place of Business ALABAMA Revenue or Assets Decline to Disclose Type of Security Equity
Canaria Therapeutics, Inc. See All Filings	D	2018-10-24 14:17:40 UTC
Amount To Be Raised $29,536 Associated Brokers / Dealers N/A CIK Number 0001754404 Filed Document 0001754404-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-10-24 14:17:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business ALABAMA Revenue or Assets Decline to Disclose Type of Security Equity